BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/12/2025 8:18:20 AM | Browse: 16 | Download: 94
Publication Name World Journal of Experimental Medicine
Manuscript ID 104678
Country India
Received
2025-01-06 05:25
Peer-Review Started
2025-01-07 02:19
To Make the First Decision
Return for Revision
2025-02-11 08:04
Revised
2025-02-26 11:17
Second Decision
2025-04-09 02:40
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2025-04-09 08:39
Articles in Press
2025-04-09 08:39
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2025-05-08 08:32
Publish the Manuscript Online
2025-08-12 08:18
ISSN 2220-315x (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Biotechnology & Applied Microbiology
Manuscript Type Minireviews
Article Title Flavonoids extract from Vitex negundo inhibit autophagy by targeting PI3K/AKT/mTOR/p70S6K/ULK signaling cascade in cancerous cells
Manuscript Source Invited Manuscript
All Author List Gunjan Garg, Shweta Chaudhary, Kalpana Khatana and Alok Bharadwaj
ORCID
Author(s) ORCID Number
Gunjan Garg http://orcid.org/0000-0002-6971-1981
Shweta Chaudhary http://orcid.org/0009-0000-9727-6414
Kalpana Khatana http://orcid.org/0009-0003-0328-0044
Alok Bharadwaj http://orcid.org/0000-0002-7383-188X
Funding Agency and Grant Number
Corresponding Author Alok Bharadwaj, Associate Professor, PhD, Department of Biotechnology, GLA University, 17 Km Mile Stone, Mathura-Delhi Highway NH-1, Post-Chaumuhan District, Mathura 281406, Uttar Pradesh, India. alok.bhardwaj@gla.ac.in
Key Words Cancer; Flavonoids; Inhibitors; Phosphoinositide 3-kinase-protein kinase B-mammalian target of rapamycin; Vitex negundo
Core Tip We try to emphasize in this medical literature how different signaling pathways contribute to the development of different types of cancer. Anticancer medications are known to target the phosphoinositide 3-kinase-protein kinase B-mammalian target of rapamycin pathway. Vitex negundo (V. negundo) is one of the very crucial plants that have wide packages in traditional structures of medicines. All a part of the plant from root to fruit possess multitude of phytochemicals as secondary metabolites. As discuss above V. negundo is a very good supply of flavonoids. Flavonoids are recommended as anticancer retailers because of their natural assets, price-effectiveness, and ease of use. Their intrinsic properties, such as restricted bioavailability, rapid metabolism, untargeted transport, and cytotoxicity to normal cells, prevent their full clinical potential from being discovered. The efficient use of a combination of flavonoids has been suggested to boost their anticancer efficacy, taking into account the potential to concurrently impact unique signaling cascades. The usage of superior strategies, along with diverse nanotechnology-based methods, is likewise advised to mitigate the stated drawbacks. Incorporating them with current chemotherapeutic tablets could resource in lowering vital doses, in the end main to fewer aspect results.
Publish Date 2025-08-12 08:18
Citation <p>Garg G, Chaudhary S, Khatana K, Bharadwaj A. Flavonoids extract from Vitex negundo inhibit autophagy by targeting PI3K/AKT/mTOR/p70S6K/ULK signaling cascade in cancerous cells. <i>World J Exp Med</i> 2025; 15(3): 104678</p>
URL https://www.wjgnet.com/2220-315X/full/v15/i3/104678.htm
DOI https://dx.doi.org/10.5493/wjem.v15.i3.104678
Full Article (PDF) WJEM-15-104678-with-cover.pdf
Manuscript File 104678_Auto_Edited_015703.docx
Answering Reviewers 104678-answering-reviewers.pdf
Audio Core Tip 104678-audio.mp3
Conflict-of-Interest Disclosure Form 104678-conflict-of-interest-statement.pdf
Copyright License Agreement 104678-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate 104678-non-native-speakers.pdf
Peer-review Report 104678-peer-reviews.pdf
Scientific Misconduct Check 104678-scientific-misconduct-check.png
Scientific Editor Work List 104678-scientific-editor-work-list.pdf
CrossCheck Report 104678-crosscheck-report.pdf